Physician profile
Debra Linzer
NPI 1851398945
$584.28
in general payments reported to CMS, 2019-2025
19 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $34.76 · 2021: $8.06 · 2022: $41.26 · 2023: $58.14 · 2024: $117 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $110.31 | 2025 | Gammatile |
| Trisalus Life Sciences, INC. | $99.49 | 2024 | Trinav Infusion System |
| Boston Scientific Corporation | $55.11 | 2022-2025 | Spaceoar Vue System - 10ml |
| E.R. Squibb & Sons, L.L.C. | $37.34 | 2019 | |
| Reflexion Medical, INC. | $36.29 | 2023 | Reflexion Medical Radiotherapy System |
| Dendreon Pharmaceuticals LLC | $25.47 | 2025 | Provenge |
| Daiichi Sankyo INC. | $24.38 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.28 | 2019 | |
| Medtec LLC | $21.85 | 2023 | |
| Foundation Medicine, INC. | $17.78 | 2020 | |
| Pfizer INC. | $17.66 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.45 | 2019 | |
| Tempus Ai, INC | $17.21 | 2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $16.98 | 2020 | |
| Celgene Corporation | $15.48 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Helsinn Therapeutics (U.S.), INC. | $14.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.47 | 2019 | |
| Shire North American Group INC | $10.87 | 2019 | |
| Ambu INC. | $8.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Linzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.